Effectiveness of etrasimod in ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This study looks at how well the daily pill etrasimod works for people with moderate to severe ulcerative colitis. It's for patients whose doctor has already decided to prescribe etrasimod as part of their routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 64 years old and have been diagnosed with moderate to severe ulcerative colitis.
- Your doctor has decided to start you on etrasimod (a daily pill) as part of your regular care.
- You do not have symptoms of Crohn's disease or very severe UC that needs hospitalization or surgery soon.
- You have never taken etrasimod or other advanced UC treatments like biologics, JAK inhibitors, or S1P modulators.
- You own a digital device (smartphone, tablet, or computer) with internet and are willing to answer health questionnaires on it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
This trial tests if the medicine etrasimod can help children with moderate to severe ulcerative colitis. You may still be able to join even if you are already taking other treatments for your condition.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
This trial tests two different medicines, infliximab and upadacitinib, to see which works better for people with severe ulcerative colitis that hasn't improved after 3 days of IV steroids. The goal is to find the best rescue option to help you feel better and avoid surgery.
This study is looking at how well etrasimod works for people with active ulcerative colitis. If you are already taking etrasimod and started it within the last 6 months, you may be able to join and help researchers learn more about its benefits.
This trial tests an oral medication called etrasimod for elderly patients with active ulcerative colitis. It aims to see if the drug is safe and effective in reducing inflammation and symptoms.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.